| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Catherine R Kinney last filed a Form 4 in June 2024, as Director at MET. The filings on record cover 2 companies. Catherine R Kinney's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Our model assigns Catherine R Kinney a below-average insider score of 27/100, based on 3 past trades. Over a 12-month horizon, none of those trades were profitable, with an average 12-month return of -3.8%.
At the last filing, the largest reported position was 19,314 shares of MSCI. The MSCI filings lean toward selling, a net 3,267 shares.
Catherine R Kinney has 85 Form 4 filings on record from March 2015 to June 2024, across 2 companies: Director at Metlife (MET), 2020–2024; Director at Msci (MSCI), 2015–2024.
The 103 reported transactions were 91 stock awards, 7 gifts and 5 open-market sales.
Counted by filing, the open-market trades come to no purchases and 3 sales worth about $1.8M.
The largest open-market sale was 2,399 shares of MSCI at an average $502.52 on November 16, 2022, about $1.2M. Twelve months later MSCI was up 3%.
Shares as reported in the last Form 4 for each company; the most recent is from June 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.